<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">NONOXYNOL-9</span><br/>(noe-nox'ee-nole)<br/><span class="topboxtradename">Conceptrol, </span><span class="topboxtradename">Delfen, </span><span class="topboxtradename">Emko, </span><span class="topboxtradename">Gynol II, </span><span class="topboxtradename">Koromex<br/></span><b>Classifications:</b> <span class="classification">spermicide contraceptive</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1%, 2%, 2.2%, 3.5%, 4%, 5% gel; 8%, 12.5% foam; 2.27%, 100 mg, 150 mg suppositories</p>
<h1><a name="action">Actions</a></h1>
<p>Nonionic surfactant spermicidal incorporated into foams, gels, jelly, or suppositories.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Applied over the cervix, blocks entrance to uterus by sperm, traps and absorbs seminal fluid, then releases the immediately
         available spermicide. Immobilizes sperm by cell membrane disruption.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>As barrier contraceptive alone or in conjunction with a vaginal diaphragm or with a condom.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Cystocele, prolapsed uterus, sensitivity or allergy to polyurethane or to nonoxynol-9; vaginitis; history of TSS; pregnancy;
         immediately after delivery or abortion; during menstruation.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Contraceptive</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply or insert 3060 min before intercourse. Repeat before each intercourse<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Apply foams, gels, jelly, cream: Fully load intravaginal applicator and insert about <small>2/3</small> of its length [7.510
            cm (34 in.)] into vagina.
         </li>
<li>Use with diaphragm: Place 13 tsp spermicide formulation in dome prior to insertion. After diaphragm is in place, additional
            spermicide is recommended. Leave spermicide and diaphragm in place 6 h after intercourse.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Urogenital:</span>
<span class="speceff-common">Candidiasis;</span> vaginal irritation and dryness; increase in vaginal infections; menstrual and nonmenstrual <span class="speceff-life">toxic shock syndrome (TSS)</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> intravaginal <span class="classification">azole antifungals</span> may inactivate the spermicides. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> Spermicidal action is prompt upon contact with sperm; minimal systemic absorption. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Stop using nonoxynol-9 if pregnancy is suspected.</li>
<li>Report symptoms of vaginal infection to physician: Burning, inflammation, intense vaginal and vulvar itching, cheesy, curd-like
            discharge, painful intercourse, dysuria. Nonoxynol-9 antifungal properties are weaker than its antibacterial potency, thus
            vulvovaginal candidiasis frequently occurs.
         </li>
<li>Use spermicide before the first and every subsequent act of intercourse.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>